Media Database
>
John LaMattina

John LaMattina

Contributor at Forbes Online

Contact this person
Email address
i*****@*******.comGet email address
Influence score
73
Location
United States
Languages
  • English
Covering topics
  • Health & Medicine

View more media outlets and journalists by signing up to Prowly

View latest data and reach out all from one place
Sign up for free

Recent Articles

forbes.com

Does Federally Funded Research Justify A Piece Of Pharma’s Profits? - Forbes

The thought that all drugs arise from government funded research is a fallacy.
forbes.com

The Flaws In Florida’s Plan To Import Drugs From Canada

The FDA had been previously reluctant to approve such a plan for safety concerns.
forbes.com

Insurers Should Start Paying For Life-Changing Weight Loss Drugs - ...

Ultimately, these drugs will also lower the nation’s healthcare bill. They should be made available to all who need them. Insurance companies need to make this happen as soon as possible.
forbes.com

Biopharma Has No Choice But To Comply With Price Controls - Forbes

Medicare will save money but there will be fewer new medicines.
forbes.com

To Really Impact Healthcare Costs Look Beyond Drug Prices - Forbes

At a time when the opportunities for discovering and developing new medicines is the greatest in our history, we will be doing less. What we really should be doing is investing more in order to generate new medicines thus reducing downstream healthcare costs.
forbes.com

Are TV Drug Ads Bad For Your Health? - Forbes

So, why do people hate TV drug ads? Based on a survey conducted by STAT, the reasons vary.People also hate the descriptions of the side effects that drugs can cause.
forbes.com

New Data Indicates That Viagra May Protect Against Heart Disease - ...

The general population of men who had taken ED drugs had a 13% lower rate of MACE, 25% lower rate of mortality and 39% lower rate of CV mortality when compared to men who had not been exposed to ED drugs.
forbes.com

Will The Government Set Price Controls For Covid-19 Vaccines? - Forbes

With the government no longer in the Covid-19 business, payment for these vaccines has now been passed on to insurers as happens with all vaccines.
forbes.com

The Ignorance Of Senators Regarding Vaccine Pricing - Forbes

Federal funding for providing Covid-19 vaccines to Americans will end this month and, as a result, most people will pay for their Covid-19 vaccines shots as they do their flu shots via their health insurance.
forbes.com

Another Example Of A “Shkrelian” Drug Price Increase - Forbes

Fortunately, Shkreli’s behaviors have not been mimicked – until now.
forbes.com

Pharma Critic Wrongly Minimizes Industry’s Covid-19 Vaccine Efforts

Pfizer, which has produced the majority of Covid-19 vaccines with roughly seven billion doses to date, took no money from Operation Warp Speed (OWS) to discover, produce or distribute its vaccine.